Transitional Drugs 7
Details
| Contract Title: | Transitional Drugs 7 |
| Published Date: | Apr 9, 2026 |
| Notice Type: | Notice (PriorInformationNotice) |
| Value Banding: | High Value |
| Delivery Point: | United Kingdom |
Description:
This is a contract for the provision of Drugs that have recently lost patent - Eculizumab, Tocilizumab, Nintedanib and Omalizumab...
